(Q36415330)

14 August 2017

1 reference

title

Pharmacogenomics and lung transplantation: clinical implications (English)

1 reference

14 August 2017

1 reference

1 reference

Burckart GJ

1

1 reference

14 August 2017

Hutchinson IV

series ordinal

2

1 reference

14 August 2017

Zeevi A

series ordinal

3

1 reference

14 August 2017

publication date

7 March 2006

1 reference

The Pharmacogenomics Journal

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

301-310

1 reference

Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Current concepts and controversies in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Medical complications and management of lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Costimulation blockade with belatacept in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Clinical aspects of the MDR1 (ABCB1) gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Evidence of significant contribution from CYP3A5 to hepatic drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Impaired kidney graft survival is associated with the TNF-alpha genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Transforming growth factor-beta1 and lung allograft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Transforming growth factor beta and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Cytokine gene polymorphisms in patients infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Surrogate markers and risk factors for chronic lung allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Messenger RNA for FOXP3 in the urine of renal-allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

A role for P-glycoprotein in regulating cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

The effect of cytokine gene polymorphisms on pediatric heart allograft outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Cytokine gene polymorphisms and acute liver graft rejection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Cytokine gene polymorphism and heart transplant rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Cytokine gene polymorphisms predict acute graft rejection following renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Significance of cytokine gene polymorphism in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Effect of the TNF-alpha-promoter polymorphism on cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Cytokine gene polymorphisms and acute human liver graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Transforming growth factor beta and myocardial dysfunction following heart transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Rejection--more than the eye can see

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500376

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500376

1 reference

14 August 2017

1 reference